Home > Drug Search >
  • company_query: Alizé
  •   > 
Drug Filter
Category:
chemistry (18) biology (5)
Status:
Approved (1) Phase Ⅲ (3) Phase Ⅱ (14) Phase Ⅰ (5)
Clinical Stage:
Pending (4) Active (15) Discontinued (3)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Asthma (3) Bone marrow cancer (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (2) Chronic obstructive pulmonary disease (COPD) (2) Crohn's disease (1) Cystic fibrosis (CF) (3) Gastric cancer (1) Glioblastoma multiforme (1) Leukemia (1) Lymphoma (2) Non small cell lung cancer (NSCLC) (5) Ovarian cancer (1) Postmenopausal osteoporosis (1) Prader-Willi syndrome (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (1) Small cell lung cancer (SCLC) (1) Solid tumours (4) Type 2 diabetes (1) Head and neck cancer (1) Colorectal cancer (1) Vulvar intraepithelial neoplasia (1) Ankylosing Spondylitis (AS) (1) Hematological cancer (1) Acromegaly (1) Astrocytoma (1) Glioblastoma (1) Allergic asthma (1) Cough (1) hematological malignancies (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top